Clinical Ophthalmic Oncology (PDF)

Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center and then completed a fellowship in Ocular Oncology at Children's Hospital Los Angeles. Dr. Berry is the founder of WOO, Women in Ocular Oncology.


Jonathan Kim, MD, is Director of the Retinoblastoma Program, Attending Physician, and Associate Professor of Clinical Surgery at the Keck School of Medicine of USC. Dr. Kim provides clinical expertise in the management of pediatric intraocular tumors. He was trained at Memorial Sloan-Kettering Cancer Center, Jules Stein Eye Institute at UCLA, and the Massachusetts Eye and Ear Infirmary at Harvard Medical School. He is developing new treatment modalities to save the eyes of children with retinoblastoma and is actively engaged in new research projects. Bertil Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco. Until 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993. Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author.
Arun Singh, MD, is Director of the Cole Eye Institute at Cleveland Clinic in the Department of Ophthalmic Oncology. He is also the Series Editor for Springer's Essentials in Ophthalmology series and was the former Editor for The British Journal of Ophthalmology and is the current Editor of Ocular Oncology and Pathology.





Jesse L. Berry, MD

Assistant Professor of Clinical Ophthalmology

USC Roski Eye Institute

Children's Hospital Los Angeles

Keck School of Medicine of USC1975 Zonal